The exhibit hall at the Health Information Management and Systems Society (HIMSS) 2014 conference is pretty humungous. Even with tens of thousands of people milling around there’s still plenty of elbow room. The central part of the floor is dominated by the huge booths (some with two levels) of the industry giants. Those booths are pretty informative and impressive.
Yet I enjoy starting off by exploring the outskirts of the hall where the small booths reside. This is an admittedly hit or miss approach, but there are some real gems among the exhibitors. It’s always a learning experience for me.
A few of the interesting companies I met today for the first time are:
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
- PatientSafe Solutions (booth 3983) a point-of-care mobile solution that integrates positive patient identification workflows into existing EHRs by using a modified iPhone
- Applied Pathways (booth 3989), which offers a cloud-based platform to enable clinicians and business analysts to develop and curate clinical rules and to implement custom workflows without IT support
- Condusiv Technologies (booth 3392) whose software improves hardware performance, e.g., by optimizing input/output processes– thus reducing the need to add expensive new gear
- IMAT Solutions (booth 3792), an advanced data aggregation, analysis and reporting company
I’m sure there are many more interesting companies I haven’t met yet. I look forward to finding some of them over the next couple days.
—
By health care business consultant David E. Williams, president of the Health Business Group.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.